Médecins Sans Frontières/Doctors Without Borders (MSF) welcomes this important pricing study highlighting that potential medicines for the treatment of COVID-19 could be made available to all at affordable prices during this pandemic.
Jessica Burry, Pharmacist, MSF Access Campaign
“This pricing study shows clearly that potential medicines to treat COVID-19 are not at all expensive to produce and could be priced such that anyone who needs treatment should be able to access it. Several of the treatments being trialed for COVID-19 are currently priced much higher than these estimates show they should be. Literally every single person on earth is susceptible to this pandemic—now is not the time for price gouging and pandemic profiteering. Patents and monopolies will only result in limited supply and unnecessarily high prices. Rationing drugs because of high prices and limited supply will only serve to prolong the pandemic. What good is a lifesaving drug if you can’t afford it?”
*Minimum costs to manufacture new treatments for COVID-19, Journal of Virus Eradication
For more information, please contact:
+41-79 203 13 02